NOREVA Sensidiane cream sensitive combination skin, 40 ml

Instructions for use for NOREVA Sensidiane cream sensitive combination skin, 40 ml

Directions for use of the article Sensidiane Cream: - Sensidiane Cream has been specially developed for people with easily irritated facial skin. - The cream relieves symptoms such as tingling, prickling, swelling, feelings of heat or tension, pain or itching. - Sensidiane cream normalises the sensitivity and tolerance threshold of the skin. - The skin's barrier function is restored. - The cream moisturises and soothes the skin. - Sensidiane Cream protects the skin from external irritants. - Skin redness is visibly reduced and the complexion appears more even. - The cream improves the quality of life through lasting well-being and a pleasant feeling of freshness. - Sensidiane cream is also suitable as an excellent make-up base. - The active ingredients include Neutrazene Pro, Fig Extract, Enantia Chlorantha (mattifying and sebum-regulating) and an ultra-fine texture (Matisoft). - The cream is suitable for oily skin that does not tolerate classic moisturisers. - Sensidiane cream is applied to cleansed skin on the face and neck in the morning and/or evening. - Die Inhaltsstoffe der Creme sind Aqua (Wasser), Isononyl Isononanoate, Butylene Glycol, Glycerin, Squalene, Hydrogenated Starch Hydrolysate, C20-22 Alkyl Phosphate, C20-22 Alcohols, Cetearyl Alcohol , Pentylene Glycol, Phenoxyethanol, Methyl Methacrylate Crosspolymer, Cetyl Alcohol, Ficus Carcia (Fig) Fruit Extract, Glyceryl / Betaine Polyacrylate, Dilinoleic Acid / Propanediol Copolymer, Hydrierte pflanzliche Glyceride, Xanthan Gum, Chlorphenesin, Glycine Soja (Sojabohnen) Öl, Glycine Soja (Sojabohnen) Sterole, Natriumhydroxid, Phytosteryl Sunflowerseedate, Enantia Chlorantha Extract, Disodium EDTA, Allantoin, Hexyl Laurate, Persea Gratissima (Avocado) Oil, Caprylyl Glycol, Sorbic Acid, Oleanic Acid, Ascorbic Acid, Dextran, Palmitoyl Tripeptide 8. - Die Quelle der Informationen ist www.laboratoires-noreva.de (Stand: 12/2019).